الصفحة الرئيسية>>Proteins>> Viral Antigens>> Malaria>>(R)-(+)-Trityl glycidyl ether

(R)-(+)-Trityl glycidyl ether (Synonyms: (R)-Trityl Glycidol)

رقم الكتالوجGC49167

A synthetic precursor

Products are for research use only. Not for human use. We do not sell to patients.

(R)-(+)-Trityl glycidyl ether التركيب الكيميائي

Cas No.: 65291-30-7

الحجم السعر المخزون الكميّة
1 g
67٫00
متوفر
5 g
235٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

(R)-(+)-Trityl glycidyl ether is a precursor that has been used in the synthesis of glycerophospholipids, as well as compounds with antiviral and antimalarial activities.1,2,3

1.Hendrickson, H.S., and Hendrickson, E.K.A facile asymmetric synthesis of glycerol phospholipids via tritylglycidol prepared by the asymmetric epoxidation of allyl alcohol. Thiolester and thioether analogs of phosphatidylcholineChem. Phys. Lipids53(1)115-120(1990) 2.Baszczyski, O., Jansa, P., Dra?ÍnskÝ, M., et al.Synthesis and antiviral activity of N9-[3-fluoro-2-(phosphonomethoxy)propyl] analogues derived from N6-substituted adenines and 2,6-diaminopurinesBioorg. Med. Chem.19(7)2114-2124(2011) 3.Sato, E., Morita, M., Ogawa, H., et al.Design, synthesis and anti-malarial activities of synthetic analogs of biselyngbyolide B, a Ca2+ pump inhibitor from marine cyanobacteriaBioorg. Med. Chem. Lett.28(3)298-301(2018)

مراجعات

Review for (R)-(+)-Trityl glycidyl ether

Average Rating: 5 ★★★★★ (Based on Reviews and 26 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (R)-(+)-Trityl glycidyl ether

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.